The objectives of this study were to quantify colonic cytokine and endothel
ial cell adhesion molecule (ECAM) expression in the colons of severe combin
ed immunodeficient (SCID) mice reconstituted with different subsets of CD4 T lymphocytes. We found that animals injected with CD45RB(high) but not CD
45RB(low) T cells or phosphate-buffered saline (PBS) developed clinical evi
dence of colitis at 6-8 weeks following reconstitution, as assessed by loss
of body weight, development of loose stools and/or diarrhea, and histopath
ology. Concurrent with the onset of distal bowel inflammation was enhanced
expression of a variety of Th1 and macrophage-derived cytokines including i
nterferon gamma, tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6
, IL-12, and IL-18 lymphotoxin-beta. In addition, message levels and vascul
ar surface expression of ICAM-1, VCAM-1, and MAdCAM-1 were all significantl
y enhanced in the colitic SCID mice reconstituted with CD45RB(high) T cells
compared with SCID mice reconstituted with PBS or CD45RB(low) T cells that
did not develop disease. Significant increases in some of these ECAMs were
also noted in the cecum and stomach and to a lesser degree in the small bo
wel. Our data confirm that reconstitution of SCID mice with CD45RB(high) bu
t not CD45RB(low) T cells induces chronic colitis, and that the colonic inf
lammation is associated with enhanced expression of proinflammatory cytokin
es and different ECAMs in the colon. Furthermore, our studies demonstrate t
hat reconstitution of SCID mice with CD45RB(high) T cells enhances ECAM exp
ression in tissues distant from the site of active inflammation.